Asparaginase-associated pancreatitis in chemotherapy-treated pediatric patients: a five-year retrospective study

Affiliations

¹ Department of Pediatric Hematology and Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
² Department of Pediatric Intensive Care Unit, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

Chen-Xi Liu et al. World J Emerg Med. 2022.

. 2022;13(4):313-321.

doi: 10.5847/wjem.j.1920-8642.2022.062.

¹ Department of Pediatric Hematology and Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
² Department of Pediatric Intensive Care Unit, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

No abstract available

Conflict of interest statement

Conflicts of interests: The authors have no competing interests.

1. Narta UK, Kanwar SS, Azmi W. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit Rev Oncol Hematol. 2007;61(3):208–21. - PubMed
1. Ettinger LJ, Ettinger AG, Avramis VI, Gaynon PS. Acute lymphoblastic leukaemia:a guide to asparaginase and pegaspargase therapy. BioDrugs. 1997;7(1):30–9. - PubMed
1. Sallan SE, Gelber RD, Kimball V, Donnelly M, Cohen HJ. More is better!Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials. Haematol Blood Transfus. 1990;33(4):459–66. - PubMed
1. Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, et al. Improved outcome for children with acute lymphoblastic leukemia:results of Dana-Farber Consortium Protocol 91-01. Blood. 2001;97(5):1211–8. - PubMed
1. Keating MJ, Holmes R, Lerner S, Ho DH. L-asparaginase and PEG asparaginase—past, present, and future. Leuk Lymphoma. 1993;10(Suppl):153–7. - PubMed